Registered Nurse in Boston, MA Accepting Medicare
1241 Registered Nurse nurses found. Showing 1 - 20
 Asa Paris, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 780 Albany St, Boston, MA 02118 Phone: 857-654-1000 |
Enid Ramos, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 780 Albany St, Boston, MA 02118 Phone: 857-654-1000 |
Mary Bates, RN Registered Nurse - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 165 Cambridge St, Mgh Crohn's And Colitis Center, Boston, MA 02114 Phone: 617-643-5524 Fax: 617-726-3080 |
Camie Doyle, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Gray-bigelow 444, Boston, MA 02114 Phone: 617-726-3030 |
 Mr. Mark James Walker, FNP-C Registered Nurse Medicare: May Accept Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-732-5000 |
Christine Elizabeth O'connor, NURSE PRACTITIONER Registered Nurse Medicare: May Accept Medicare Assignments Practice Location: 332 Hanover St, Boston, MA 02113 Phone: 617-643-8080 |
Nicaury Victoria Suazo Ortiz, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1601 Washington St, Boston, MA 02118 Phone: 617-425-2000 |
Emily Johnson, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 830 Harrison Ave Ste 3500, Boston, MA 02118 Phone: 617-638-8776 Fax: 617-414-8772 |
Alfreda Belinda Whyte, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-726-2000 |
Shivaun Elaine Bennett, RN Registered Nurse Medicare: Medicare Enrolled Practice Location: 133 Brookline Ave, Boston, MA 02215 Phone: 617-421-1000 |
Michele Dannenberg, NP, MPH Registered Nurse Medicare: Medicare Enrolled Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-632-7270 |
Mrs. Michaela O'shea, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11 Aberdeen St Apt 4a, Boston, MA 02215 Phone: 860-906-7868 |
Ms. Vickie Marie Kello, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 1010 Massachusetts Ave, Boston, MA 02118 Phone: 617-534-4222 |
Diane L. Gilworth, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 133 Brookline Ave, Boston, MA 02215 Phone: 617-421-6050 |
April Donahue, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 780 Albany St, Boston, MA 02118 Phone: 857-654-1000 |
Gina Pierre, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 780 Albany St, Boston, MA 02118 Phone: 857-654-1000 |
Andrea G Lopez, DNP, RN, CPNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6000 |
Saneeyyah Christine Rain Carter, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Boston Medical Ctr Pl, Dowling North Suite 5108, Boston, MA 02118 Phone: 617-638-7062 Fax: 617-638-7075 |
Mrs. Tracy Comeau-beedle, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 780 Albany St, Boston, MA 02118 Phone: 857-654-1000 |
Ms. Rachel Fawn Furman, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 150 S Huntington Ave, Boston, MA 02130 Phone: 508-649-1118 |
News Archive
Amgen's XGEVA delays onset of bone metastases in men with prostate cancer
Amgen announced today the publication of results from a Phase 3 trial (the '147 study) that evaluated XGEVA (denosumab) for use in preventing or delaying the onset of bone metastases in men with nonmetastatic castration-resistant prostate cancer.
Erivedge drug shows promise against advanced basal cell carcinoma
It's the most common form of skin cancer, but in its advanced stages, basal cell carcinoma has the potential to become disfiguring and life threatening. An international phase 2 study headed by Mayo Clinic led to the recent Food and Drug Administration approval of the first drug of its kind to help advanced basal cell carcinoma patients who have few treatment options.
Femara helps protect against return of breast cancer after completing Tamoxifen therapy
Women may reduce the risk of their breast cancer returning by starting treatment with Femara (letrozole tablets) anywhere from one to seven years after finishing tamoxifen therapy, according to a new analysis published in the Journal of Clinical Oncology.
On quality of care, U.S. is not always best
The Washington Post interviewed Sen. Kent Conrad, D-N.D., about other developed nations' health care systems: "We won't adopt the German system or French system or anything of the like. But I think we can get clues on the fundamental differences of various systems," he said. Conrad added that the system that has "largely been adopted in France, Germany, Japan, Belgium and Switzerland, is not government-run.
› Verified 2 days ago